KD Logo

Immix Biopharma Inc’s latest rating changes from various analysts

ZOM Stock

Immix Biopharma Inc’s filing revealed that its Director Hsu Jason acquired Company’s shares for reported $0.14 million on Dec 11 ’23. In the deal valued at $4.67 per share,31,000 shares were bought. As a result of this transaction, Hsu Jason now holds 813,000 shares worth roughly $2.31 million.

Then, Hsu Jason bought 25,000 shares, generating $122,025 in total proceeds. Upon buying the shares at $4.88, the Director now owns 782,000 shares.

Before that, Hsu Jason bought 7,000 shares. Immix Biopharma Inc shares valued at $17,396 were divested by the Director at a price of $2.49 per share. As a result of the transaction, Hsu Jason now holds 757,000 shares, worth roughly $2.15 million.

Price Performance Review of IMMX

On Tuesday, Immix Biopharma Inc [NASDAQ:IMMX] saw its stock fall -0.70% to $2.84. Over the last five days, the stock has lost -3.40%. Immix Biopharma Inc shares have fallen nearly -58.96% since the year began. Nevertheless, the stocks have risen 65.12% over the past one year. While a 52-week high of $7.75 was reached on 01/02/24, a 52-week low of $1.40 was recorded on 02/06/24. SMA at 50 days reached $3.13, while 200 days put it at $3.52. A total of 0.21 million shares were traded, compared to the trading of 0.16 million shares in the previous session.

Levels Of Support And Resistance For IMMX Stock

The 24-hour chart illustrates a support level at 2.77, which if violated will result in even more drops to 2.70. On the upside, there is a resistance level at 2.93. A further resistance level may holdings at 3.02. The Relative Strength Index (RSI) on the 14-day chart is 43.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.04%. Stochastics %K at 36.17% indicates the stock is a holding.

How much short interest is there in Immix Biopharma Inc?

A steep rise in short interest was recorded in Immix Biopharma Inc stocks on Mar 28, 2024, growing by 0.12 million shares to a total of 0.39 million shares. Yahoo Finance data shows the prior-month short interest on Feb 29, 2024 was 0.26 million shares. There was a rise of 32.09%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 2.09% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.86.

Most Popular

[the_ad id="945"]